An expert review and clinical practice update has recently been published by the American Gastroenterological Association which addresses endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel disease (IBD) patients.

Improvements in disease management and endoscopic technology and quality have modified the conceptualization and management of IBD-related dysplasia over the past 2 decades, wrote the authors in Gastroenterology. Fourteen best practice advice statements in the review cover an array of topics, including lesion terminology and characterization, timing of endoscopy, and indications for biopsies, resection, and colectomy.

The authors stated that all patients with chronic IBD must be subjected to colonoscopy screening for dysplasia 8-10 years following diagnosis. Further colonoscopies should be done every 1-5 years, based on the risk factors, like a family history of colorectal cancer and the quality of previous surveillance exams… (Medscape)